National Institute of Allergy & Infectious Diseases

1-4-2011As the HIV.gov blog's fourth year begins, we at HIV.gov are taking time to reflect on 2010 and look to the year ahead. As we continue to integrate monitorin…

11-23-2010WASHINGTON, D.C. – Today, the National Institutes of Health announced findings on recent HIV prevention research.  The study finds that a daily dose…

11-23-2010The National Institutes of Health National Institute of Allergy and Infectious Diseases just made a significant announcement on pre-exposure prophylaxis (PrEP).…

11-12-2010On Tuesday, October 26, more than 300 representatives from our current HIV clinical trial networks, the infectious diseases research community, and HIV advocacy…

10-21-2010Co-authored by Hugh Auchincloss, M.D., NIAID Deputy Director and Carole Heilman, Ph.D., Director of NIAID’s Division of Microbiology and Infectious Diseas…

10-19-2010Co-authored by Edward Handelsman, M.D., Chief of NIAID’s Pediatric Medicine Branch within the Division of AIDS, and Lynne Mofenson, M.D., Chief of the Ped…

9-16-2010The National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH will host a public meeting on Tuesday, October 26, 2010, in Arlington, Va., t…

8-31-2010The National Institute of Allergy and Infectious Diseases (NIAID) is developing a series of blog posts here on HIV.gov related to planning for the future of NIA…

7-30-2010Scientists have discovered two potent human antibodies that can stop more than 90 percent of known global HIV strains from infecting human cells in the laborato…

7-20-2010Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases, shared the latest scientific information with the conference delegates…